跳至主要内容
临床试验/NCT05929508
NCT05929508招募中不适用

Improving Mobility and Function Following Transfemoral Amputation: A Novel Approach to Reverse Volumetric Muscle Loss

University of Illinois at Chicago2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
2
主要终点
Strength

研究概览

简要总结

The purpose of this study is to investigate the relationship between thigh strength and walking ability and assess if using a blood pressure cuff on the leg improves strength and walking performance.

详细描述

One in every 190 Americans is currently living with the loss of a limb. Following lower limb amputation (LLA), individuals have double the risk of knee and hip pain, a high prevalence of osteoarthritis in the intact limb with a prevalence ratio of 3.3 compared to those without amputation, and up to 90% experience severe back pain. The long-term consequences of LLA may be mitigated through regular use of prosthesis and physical activity, which would also increase the likelihood of returning to work and reintegration of Service Members (SMs) and younger Veterans.

Clinicians and researchers often focus on the prosthetic fit to improve outcomes, however just providing a prosthetic, even the most advanced prosthetic, is not enough to restore function. Interventions targeting physical capabilities to complement device intervention may be key to improving outcomes in individuals with LLA.

Along with increased orthopaedic risks, individuals with traumatic LLA also have an increased risk of cardiovascular events compared to the general population. SMs with traumatic unilateral transfemoral amputation have a 1.58 times greater risk of death from cardiovascular causes and their relative risk of aortic aneurysm is 5.1 times greater than Veterans without amputation. There is evidence to suggest that individuals with LLA have increased peripheral vascular resistance following amputation, leading to vasoconstriction and increased blood pressure. Reduced arterial function (i.e. increased arterial stiffness) is an important measure in those with LLA because it predicts mortality, heart failure, and cardiovascular events. In addition, improved arterial function improves perfusion to muscle and reduces fatigue during exertion. Therefore, strategies that reduce arterial stiffness and vascular resistance in individuals with LLA are important to improve mortality and quality of life for SMs and Veterans.

Therefore, we propose implementing ischemic preconditioning (IC) as a novel intervention to strengthen and hypertrophy leg muscles and increase arterial function for improving outcomes after amputation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •At least 18 years old
  • •History of lower limb unilateral transfemoral amputation.
  • •At least two years post lower limb amputation
  • •Able to ambulate independently without the use of aids (i.e., walking cane).
  • •Able to walk at least 10 minutes continuously without stopping.
  • •Has a safe residuum with no open wounds on either the residual or intact limb.
  • •Has a prosthetic limb with materials that are sound and safe to withstand the mobility requirements of the study.

排除标准

  • •Younger than 18 years old.
  • •Inability to give informed consent.
  • •Neurological disorder that affects gait.
  • •Participants with significant metal (greater than one orthopaedic screw) in either the residual limb or the sound/intact limb
  • •Participants who begin taking medications or change dosage of medications that could affect gait, balance, and cardiovascular function during the course of the study.
  • •Currently pregnant (or intend to become pregnant while participating in study).
  • •History of any condition where fatiguing contractions or resisted leg contractions are contraindicated.
  • •Blood clots in the leg, or any condition in which compression of the thigh or transient ischemia is contraindicated (e.g. open wounds in the leg).
  • •History of uncontrolled hypertension.
  • •History of heart failure.
  • •Head injury within the previous 6 months.
  • •Seizure disorder.
  • •History of vascular disease.
  • •History of thrombosis.
  • •History of sickle cell trait.
  • •History of genetic disease

研究组 & 干预措施

Ischemic Preconditioning at High Pressure

Active Comparator

In this arm, the participant will receive ischemic preconditioning (a blood pressure cuff on the intact limb) inflated to 225mmHg for 5 minutes followed by 5 minutes of reperfusion on a cycle for a total of 50 minutes. This will be completed every other day for 7 session (14 days).

干预措施: Ischemic Preconditioning (Other)

Ischemic Preconditioning at Low Pressure

Sham Comparator

In this arm, the participant will receive ischemic preconditioning (a blood pressure cuff on the intact limb) inflated to 25mmHg for 5 minutes followed by 5 minutes of reperfusion on a cycle for a total of 50 minutes. This will be completed every other day for 7 session (14 days).

干预措施: Ischemic Preconditioning (Other)

结局指标

主要结局

Strength

时间窗: through study completion, an average of 6 weeks

Comparing leg strength before and after intervention

Metabolics

时间窗: through study completion, an average of 6 weeks

Comparing leg strength before and after intervention

Gait

时间窗: through study completion, an average of 6 weeks

Comparing leg strength before and after intervention

Arterial Stiffness

时间窗: through study completion, an average of 6 weeks

Comparing leg strength before and after intervention

Daily Steps/Activity

时间窗: through study completion, an average of 6 weeks

Comparing leg strength before and after intervention

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lindsay Hannigan

Assistant Professor

University of Illinois at Chicago

研究点 (2)

Loading locations...

相似试验